Sharekhan

Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.

Market Data

Essential tool: analyze, trade, manage, decide.

What’s Your Call?

Collective community sentiment on Dhansa Labs Ltd

Your Vote -

Buy

60.00%

Hold

10.00%

Sell

30.00%

60.00%

10 users have voted

Market Depth

How many stocks are available to buy or sell and at what prices.

Buy Order Quantity

0%

Sell Order Quantity

100%

Bid Price

Qty

0.00

0

0.00

0

0.00

0

0.00

0

0.00

0

Bid Total

0

Bid Price

Qty

37.05

12000

0.00

0

0.00

0

0.00

0

0.00

0

Bid Total

12000

Option Chain

Analyzes market sentiment, predicts Dhansa Labs Ltd' movement.

NO_RECORD_FOUND

News

Media spotlight triggers stock stock attention, sentiment.

  • Dhansa Labs has submitted to BSE the Shareholding Pattern for the Period Ended May 26, 2026

    12 Jun 2026, 11:50AM As of May 2026, 65.05% is owned by Indian Promoters and 34.95% by Public. <p align=justify> Top three Promoters holding highest number of shares of Dh
  • Dhansa Labs - Analysts/Institutional Investor Meet/Con. Call Updates

    11 Jun 2026, 4:15PM Dhansa Labs Limited has informed the Exchange about Transcript
  • Dhansa Labs - Analysts/Institutional Investor Meet/Con. Call Updates

    6 Jun 2026, 6:24PM Dhansa Labs Limited has informed the Exchange about Link of Recording
  • Dhansa Labs - Investor Presentation

    5 Jun 2026, 4:57PM Dhansa Labs Limited has informed the Exchange about Investor Presentation
  • Dhansa Labs - Analysts/Institutional Investor Meet/Con. Call Updates

    2 Jun 2026, 5:57PM Dhansa Labs Limited has informed the Exchange about Schedule of meet
  • Dhansa Labs Q4 net profit jumps 78.63% at Rs 2.09 cr

    2 Jun 2026, 11:40AM The company reported standalone net profit of Rs 2.09 crore for the quarter ended March 31, 2026 as compared to Rs 1.17 crore in the same period last
  • Dhansa Labs Q3 net profit jumps 56.92% at Rs 1.02 cr

    2 Jun 2026, 11:40AM The company reported standalone net profit of Rs 1.02 crore for the quarter ended December 31, 2025 as compared to Rs 0.65 crore in the same period la
  • Ambey Laboratories - Outcome of Board Meeting

    30 May 2026, 12:10AM Ambey Laboratories Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026.
  • Ambey Laboratories has submitted to BSE the Shareholding Pattern for the Period Ended May 12, 2026

    27 May 2026, 3:50PM As of May 2026, 65.94% is owned by Indian Promoters and 34.06% by Public. <p align=justify> Top three Promoters holding highest number of shares of Am
  • Ambey Laboratories - Name and Symbol Change

    26 May 2026, 5:10PM AMBEY: Members of the Exchange are hereby informed that the name of Ambey Laboratories Limited shall be changed to Dhansa Labs Limited and symbol be c
  • Ambey Laboratories - Name Change

    26 May 2026, 4:05PM Ambey Laboratories Limited has informed the Exchange regarding the change in the name and symbol of the Company from Ambey Laboratories Limited to
  • Ambey Laboratories - Committee Meeting Updates

    26 May 2026, 1:07PM Ambey Laboratories Limited has informed the Exchange regarding Outcome of Committee Meeting held on May 26, 2026.
  • Ambey Laboratories - Disclosure under SEBI Takeover Regulations

    26 May 2026, 1:06PM DHANSA LABS LIMITED has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substanti
  • Ambey Laboratories - Updates

    19 May 2026, 7:01PM Ambey Laboratories Limited has informed the Exchange regarding 'Undertaking regarding inadvertent omission of Chartered Accountant s Certificate in th
  • Ambey Laboratories - Outcome of Board Meeting

    19 May 2026, 4:31PM Ambey Laboratories Limited has informed the Exchange regarding Outcome of Board Meeting held on May 19, 2026.
  • Ambey Laboratories - Committee Meeting Updates

    12 May 2026, 10:44AM Ambey Laboratories Limited has informed the Exchange regarding Outcome of Committee Meeting held on May 12, 2026.
  • Ambey Laboratories - Updates

    11 May 2026, 5:41PM Ambey Laboratories Limited has informed the Exchange regarding 'Initial Disclosure with respect to Non-applicability of Large Corporate Framework pu
  • Ambey Laboratories has submitted to BSE the Shareholding Pattern for the Period Ended April 22, 2026

    11 May 2026, 1:20PM As of April 2026, 67.78% is owned by Indian Promoters and 32.22% by Public. <p align=justify> Top three Promoters holding highest number of shares of
  • Ambey Laboratories - General Updates

    8 May 2026, 1:08PM Ambey Laboratories Limited has informed the Exchange about General Updates
  • Ambey Laboratories - Outcome of Board Meeting

    1 May 2026, 7:10PM Outcome of Board Meeting and Intimation for Allotment of 3,63,043 (Three Lakh Sixty-ThreeThousand Forty-Three) Equity Shares pursuant to exercise of C
  • Ambey Laboratories - General Updates

    23 Apr 2026, 10:56AM Ambey Laboratories Limited has informed the Exchange about General Updates
  • Ambey Laboratories - Outcome of Board Meeting

    22 Apr 2026, 7:04PM Outcome of Board Meeting and Intimation for Allotment of 8,69,565 (Eight Lakh Sixty-Nine Thousand Five Hundred Sixty-Five) Equity Shares pursuant to e
  • Ambey Laboratories - Price movement

    22 Apr 2026, 5:31PM Significant movement in price has been observed in Ambey Laboratories Limited. The Exchange, in order to ensure that investors have latest relevant in
  • Ambey Laboratories has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2026

    21 Apr 2026, 9:20AM As of March 2026, 70.15% is owned by Indian Promoters and 29.85% by Public. <p align=justify> Top three Promoters holding highest number of shares of
  • Ambey Laboratories - Certificate under SEBI (Depositories and Participants) Regulations, 2018

    10 Apr 2026, 4:40PM Ambey Laboratories Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
  • Ambey Laboratories - Updates

    6 Apr 2026, 4:38PM Ambey Laboratories Limited has informed the Exchange regarding 'Intimation under regulation 31(4) and 31(5) of the SEBI (Substantial Acquisition of
  • Ambey Laboratories - Agreements

    28 Mar 2026, 3:51PM Ambey Laboratories Limited has informed the Exchange about Agreements
  • Ambey Laboratories - Trading Window

    27 Mar 2026, 6:17PM Ambey Laboratories Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulation
  • Ambey Laboratories - General Updates

    25 Mar 2026, 8:02PM Ambey Laboratories Limited has informed the Exchange about General Updates
  • Ambey Laboratories - General Updates

    24 Mar 2026, 1:15PM Ambey Laboratories Limited has informed the Exchange about General Updates

Key fundamentals

Evaluate the intrinsic value of Dhansa Labs Ltd stock 

Name March-26 March-25 March-24 March-23 March-22
Assets 138.6327 117.1933 61.1575 37.2882 37.1153
Liabilities 138.6327 117.1933 61.1575 37.2882 37.1153
Equity 24.9468 24.9468 18.6888 17.7494 17.7494
Gross Profit 10.915 9.5768 9.0721 8.4138 10.3409
Net Profit 5.7326 4.7827 7.7217 4.5693 3.5747
Cash From Operating Activities -0.9986 -34.4823 -12.9421 9.4411 5.6073
NPM(%) 4.05 3.64 6.4 4.35 4.22
Revenue 141.5372 131.2699 120.4714 104.8212 84.6007
Expenses 130.6222 121.6931 111.3993 96.4074 74.2598
ROE(%) 6.83 5.7 9.21 5.45 4.26

Shareholding Pattern

Corporate Action

XD-Date Dividend-Amount Dividend-% Dividend Yield(%GE) Price on that day

Peers

Other companies within the same industry or sector that are comparable to Dhansa Labs Ltd

Company Price Price (% change) pe(x) EV/EBITDA(x) ROE(%) ROCE(%)
Nitta Gelatin India Ltd 1414.20 6.83 13.20 0.00 1071.07 0.00
Sharda Cropchem Ltd 923.35 5.44 12.23 0.00 754.66 1.62
Amines and Plasticizers Ltd 190.18 1.40 28.64 0.00 331.99 0.26
Indogulf Cropsciences Ltd 60.64 8.58 9.58 0.00 63.31 0.00

Company Info

Our Company was originally incorporated as a private limited company namely "Ambey Laboratories Private Limited" under the Companies Act, 1956 vide certificate of incorporation dated 20/03/1985 issued by Registrar of Companies, NCT of Delhi bearing registration no. 020490. Further, Our Company was converted into a Public Limited Company in pursuance of a special resolution passed by the members of our Company at the Extra Ordinary General Meeting held on November 15th 2014. A fresh Certificate of Incorporation consequent to conversion was issued on December 30th 2014 by the Registrar of Companies, NCT of Delhi and consequently the name of our Company was changed from "Ambey Laboratories Private Limited" to "Ambey Laboratories Limited". The Company's Corporate Identification Number is U74899DL1985PLC020490.MAJOR EVENTS AND MILESTONES:1985Our Company was incorporated as a Private Limited Company under the name "Ambey Laboratories Private Limited".2014Our Company was converted into Public Limited Company under the name "Ambey Laboratories Limited".

Our Company was originally incorporated as a private limited company namely "Ambey Laboratories Private Limited" under the Companies Act, 1956 vide certificate of incorporation dated 20/03/1985 issued by Registrar of Companies, NCT of Delhi bearing registration no. 020490. Further, Our Company was converted into a Public Limited Company in pursuance of a special resolution passed by the members of our Company at the Extra Ordinary General Meeting held on November 15th 2014. A fresh Certificate of Incorporation consequent to conversion was issued on December 30th 2014 by the Registrar of Companies, NCT of Delhi and consequently the name of our Company was changed from "Ambey Laboratories Private Limited" to "Ambey Laboratories Limited". The Company's Corporate Identification Number is U74899DL1985PLC020490.MAJOR EVENTS AND MILESTONES:1985Our Company was incorporated as a Private Limited Company under the name "Ambey Laboratories Private Limited".2014Our Company was converted into Public Limited Company under the name "Ambey Laboratories Limited".

Read More

Parent Organisation

Dhansa Labs Ltd.

Founded

20/03/1985

Managing Director

NSE Symbol

DHANSAST

FAQ

The current price of Dhansa Labs Ltd is

The 52-week high for Dhansa Labs Ltd is

The market capitalization of Dhansa Labs Ltd is currently This value can fluctuate based on stock price movements and changes in the number of shares outstanding.

To buy Dhansa Labs Ltd shares, you need to have a brokerage account. First, choose a reputable brokerage firm, open an account, and complete the necessary KYC procedures.

To invest in Dhansa Labs Ltd, you need a brokerage account. After opening an account and completing the KYC process, you can fund your account and use the trading platform to purchase Dhansa Labs Ltd shares.

The CEO of Dhansa Labs Ltd is , who has been leading the company with a vision to expand its renewable energy portfolio and drive sustainable growth.

OPEN FREE* DEMAT ACCOUNT